SNY News and Press, Sanofi From 02/17/26

2026-02-17 04:07:05 ET More on Sanofi Sanofi: CEO Leaves With Project Rejuvenation Unfinished, But Stock Undervalued Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Sanofi replaces CEO Paul Hudson, names ...

2026-02-17 01:11:27 ET AbbVie ( ABBV ), a leader in the JAK and IL-23 inhibitor markets, released strong Q4 numbers, but its stock price fell 5.1% that day. And first, I will note the dry numbers.... Read the full article on Seeking Alpha For further details see: AbbVie:...

2026-02-14 11:20:40 ET More on Pfizer, Moderna, etc. Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation Pfizer: A Great Opportunity Post Earnings Earnings Scorecard: Healthcare sector shows stron...

2026-02-13 15:07:01 ET It’s been a rough go for Alnylam Pharmaceuticals ( ALNY ) since October 2025, with the shares down almost 40% from an all-time high. While it is typically clinical failures that hit biotechs hard, Alnylam is in that awkward biopharma adolescence where inves...

2026-02-12 16:45:15 ET Investment Overview Sanofi ( SNY ), native ticker Euronext Paris: SAN, reported its Q4 and full-year earnings on January 29th, announcing net sales up >9.9% year-on-year, to €43.6bn in 2025, and net income up >12%, to €9.6bn.... ...

2026-02-12 02:03:48 ET More on Sanofi Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi anticipates profitable gro...

2026-02-11 11:47:21 ET More on Sanofi Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Sanofi anticipates profitable gro...

2026-02-11 09:46:31 ET Denver, Colorado- Innovation-driven small caps are setting the tone this morning, with developments spanning advanced biomaterials, animal health biotech, restructuring plays, balance sheet resets, share buybacks, and renewable energy SaaS expansion. Kraig Biocr...

2026-02-11 08:35:15 ET Kraig Labs Cracks the Spider Silk Code Denver, Colorado-- Kraig Biocraft Laboratories (OTCQB:KBLB) (“the Company” or “Kraig Labs”), the undisputed global leader in the development and commercialization of spider silk, is enterin...

2026-02-10 09:33:04 ET More on related tickers Novartis: Value Price, Growth Pipeline Magnum Ice Cream rallies to a post-Unilever separation high Sanofi signs share buyback for up to €1B Read the full article on Seeking Alpha For further detail...